Polycystic Ovary Syndrome

The CRE WHiRL research stream Polycystic Ovary Syndrome is led by Professors Helena Teede and Robert Norman.

(If you would like further information about a research topic please contact the relevant project lead.) 

Polycystic Ovary Syndrome is diagnosed by Rotterdam criteria as two of oligo - anovulation, hyperandrogenism and polycystic ovaries on ultrasound, affects around 13% of women and is much neglected, with high consumer dissatisfaction and long diagnostic delays. Whilst we have advanced understanding and refined diagnostic criteria through research and International Polycystic Ovary Syndrome guidelines, in CRE WHiRL, we focus on priorities from the international Polycystic Ovary Syndrome research road map  generated with input from 3500 women and health professionals internationally, evidence synthesis (40 systematic and 20 narrative reviews) and guideline development with input across 71 countries. The map focuses on the clear remaining gaps in Polycystic Ovary Syndrome knowledge as outlined below: